Trial Profile
Pitavastatin Evaluation of Atherosclerosis Regression by Intensive Cholesterol-Lowering Therapy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Pitavastatin (Primary)
- Indications Atherosclerosis
- Focus Pharmacodynamics
- Acronyms PEACE
- 03 Jul 2012 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical information Network (Japan) record.
- 03 Jul 2012 Actual end date (1 Dec 2009) added as reported by University Hospital Medical information Network (Japan) record.
- 31 Aug 2011 Results presented at the ESC Congress 2011: Annual Congress of the European Society of Cardiology.